Gastroenterologist-Lead Management of Iron Deficiency Anemia in Inflammatory Bowel Disease Is Effective, Safe, and May Increase Quality of Life

Abstract

Background: The effectiveness and safety of gastroenterologist (GI)-lead treatment of iron deficiency anemia (IDA) in inflammatory bowel disease (IBD) have not been well-studied. Methods: A retrospective chart review of patients with IBD, IDA, and evidence of treatment with iron at a tertiary IBD center was conducted. Results: In 351 patients, hemoglobin and quality of life scores increased significantly after treatment with iron. Twelve of 341 patients treated with intravenous iron had an adverse effect. Twenty-seven patients required a hematology referral. Conclusion: GIs should consider treating patients with IBD and IDA with intravenous iron as it is safe and effective. Lay Summary We reviewed records of patients with anemia and inflammatory bowel disease and found that gastroenterologists can effectively and safely treat anemia in these patients. This improved patients’ quality of life. Most patients did not need to see a separate specialist.